Background Low income, a known prognostic indicator of various chronic respiratory
diseases, has not been properly studied in idiopathic pulmonary fibrosis (IPF). We …

Background and Objectives: Idiopathic pulmonary fibrosis (IPF) has a variable clinical
course, which ranges from being asymptomatic to progressive respiratory failure. The …

Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple
comorbidities, which may influence survival but go under-recognised in clinical practice. We …

Research question There is no widely accepted grading system for IPF disease severity,
although physiologic impairment based on pulmonary function testing is frequently …

Rationale: Since their approval, there has been no real-world or randomized trial evidence
evaluating the effect of the antifibrotic medications pirfenidone and nintedanib on clinically …

Background The prognostic role of changes in body fat in patients with idiopathic pulmonary
fibrosis (IPF) remains underexplored. We investigated the association between changes in …

Background: Idiopathic pulmonary fibrosis (IPF) is the most common and severe form of
idiopathic interstitial pneumonia, and its prevalence increases with age. In the era of pre …

Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …

Background: An association between idiopathic pulmonary fibrosis (IPF) and advancing age
is suspected since IPF occurs primarily in patients over 60 years of age. Though, little is …

In patients with idiopathic pulmonary fibrosis (IPF), the effects of antifibrotic agents on the
prognosis remain unclear. This study aimed to investigate the impact of antifibrotic treatment …